Track the Sopharma AD share price and the full management transaction log of the company, a publicly traded company based in Bulgaria. Shares are quoted on BG BG, under the authority of BSE-Sofia (FSC). Operating in the Health Care sector, Sopharma AD has recorded 49 insider filings. Market capitalisation: €4.3bn. The latest transaction was disclosed on 26 May 2026 (MAR Art. 17 — Insider information). The full history is openly available.
49
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Fundamental score
Ranked 17,807 of 26,212 companies
40.0
score / 100
Value
28
Quality
52
FCF yld-1.5%
Earn yld1.6%
EV/EBITDA33.6x
ROE17%
Gross mgn23%
Net mgn4.9%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Sopharma AD is a Bulgarian company engaged in the production and distribution of pharmaceuticals. It is listed on the Bulgarian Stock Exchange under the symbol XBUL.